;

American Society of Bone and Mineral Research 2012

In this review:

Anti-sclerostin antibody AMG 785
Odanacatib improves BMD
BMD changes and fracture prediction
Antihypertensive drugs and hip fracture risk
Non-benzodiazepine hypnotics and hip fracture risk
Duration and safety of osteoporosis therapy
Osteocalcin regulates bone formation via the CNS
Denosumab + teriparatide improve BMD
Calcium supplements and CV disease risk
Oestrogen deficiency mediates bone loss in hypogonadal men
Bone loss after bariatric surgery

Please login below to download this issue (PDF)

Subscribe